DRDGOLD CFO sells 137,067 shares, R7,483,745.05 on 17 Oct 2025

Q: What did DRD disclose in this 6-K?

A director dealing by the CFO, involving an on-market sale of 137,067 DRDGOLD ordinary shares on 17 October 2025.

Q: What was the total value and pricing of the DRD CFO’s trade?

Total value was R7,483,745.05 at a VWAP of R54.599, with a highest price of R55.1 and lowest of R54.2.

Q: Was prior clearance obtained for the DRD director’s trade?

Yes. The company states that prior clearance to deal was obtained per JSE Listings Requirements.

Q: What is the nature of the CFO’s interest in the DRD shares sold?

The filing states the interest as direct beneficial.

Q: What class of DRD securities was involved?

The transaction involved ordinary shares of DRDGOLD.

Q: When was the disclosure released?

The release is dated 21 October 2025.

DRDGOLD Limited reported a director dealing: Chief Financial Officer Riaan Davel executed an on‑market sale of 137,067 ordinary shares on 17 October 2025.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

DRDGOLD Limited reported a director dealing: Chief Financial Officer Riaan Davel executed an on‑market sale of 137,067 ordinary shares on 17 October 2025. The trades were done at a VWAP of R54.599, with a highest price of R55.1 and a lowest price of R54.2, for a disclosed total value of R7,483,745.05. The interest is stated as direct beneficial.

The company notes that prior clearance to deal was obtained in accordance with JSE Listings Requirements, and the transaction was disclosed via a formal release dated 21 October 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DRD disclose in this 6-K?

A director dealing by the CFO, involving an on-market sale of 137,067 DRDGOLD ordinary shares on 17 October 2025.

What was the total value and pricing of the DRD CFO’s trade?

Total value was R7,483,745.05 at a VWAP of R54.599, with a highest price of R55.1 and lowest of R54.2.

Was prior clearance obtained for the DRD director’s trade?

Yes. The company states that prior clearance to deal was obtained per JSE Listings Requirements.

What is the nature of the CFO’s interest in the DRD shares sold?

The filing states the interest as direct beneficial.

What class of DRD securities was involved?

The transaction involved ordinary shares of DRDGOLD.

When was the disclosure released?

The release is dated 21 October 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 10/21/2025 - 03:12 PM EDT

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
______________________

FORM 6-K

REPORT OF A FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

October 21, 2025

Commission File Number 0-28800

______________________

DRDGOLD Limited

Constantia Office Park

Cnr 14th Avenue and Hendrik Potgieter Road

Cycad House, Building 17, Ground Floor

Weltevreden Park 1709

(Address of principal executive offices)

______________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F Form 40-F

Exhibit

99.1 Release dated October 21, 2025 “DEALING IN SECURITIES BY A DIRECTOR”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DRDGOLD LIMITED

Date: October 21, 2025 By: /s/ Adriaan Davel

Name: Adriaan Davel

Title: Chief Financial Officer

Exhibit 99.1

DRDGOLD LIMITED

(Incorporated in the Republic of South Africa)

(Registration number: 1895/000926/06)

ISIN: ZAE000058723

JSE & A2X share code: DRD

NYSE trading symbol: DRD

(“DRDGOLD” or the “Group”)


DEALING IN SECURITIES BY A DIRECTOR

In compliance with paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements (“Listings Requirements”), the following information regarding a transaction by a director of DRDGOLD is disclosed:


Name of Director:			Riaan Davel
Title:			Chief Financial Officer
Nature of transaction:			On-market sale of DRDGOLD ordinary shares
Class of security:			Ordinary shares
Date on which the transaction was effected:			17 October 2025
Number of ordinary shares:			137 067
Price per ordinary share:			Various different trades with the following price information: –VWAP of R54.599 –highest price of R55.1 –lowest price of R54.2
Total value of transaction:			R7 483 745.05
Nature and extent of interest:			Direct beneficial

In compliance with paragraph 3.66 of the Listings Requirements, prior clearance to deal in the above securities was obtained.

Johannesburg

21 October 2025

Sponsor

One Capital

Source: View Original Filing on SEC EDGAR